Introduction
Could you outlive your body’s expiration date?
A cancer treatment can save a life without slowing aging. Sergey Young asks what happens when medicine starts targeting aging itself, and how to distinguish today’s useful tools from tomorrow’s ambitious promises.
1. Life at 200
The wager behind living long enough
Medical progress could eventually buy people healthy years faster than time takes them away. That is “longevity escape velocity,” the model associated with David Gobel and Aubrey de Grey. If each year of advances added more than a year of remaining life, repeated treatment could theoretically keep moving death further away.
Sergey Young approaches this possibility as an investor. A high-cholesterol diagnosis prompted his interest in health, followed by the creation of his $100 million Longevity Vision Fund. His access to biotechnology companies supplies much of the book’s evidence, while also making his financial involvement part of the perspective readers should understand.
Published in 2021, the book combines existing treatments with forecasts of radical life extension. Young acknowledges that escape velocity might take a century or never arrive. The useful immediate question is which actions can preserve health while researchers test those larger ambitions.